Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide

Journal of Neuroscience

Volumn 19, Issue 4, 1999, Pages 1335-1344

  Cui, Jian Kun ^a   Hsu, Chung Y ^b   Liu, Philip K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense DNA; C fos; Drug target validation; Experimental cerebral ischemia; Gene function analysis; Gene regulation; Immediate early genes; Intracerebroventricular delivery; Neurotrophin; NGF; Oligodeoxynucleotide; Stroke; Transfection

Indexed keywords

ACTIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; BIOTIN; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; BRAIN VENTRICLE; CONTROLLED STUDY; DENTATE GYRUS; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSFECTION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; STROKE;

EID: 0033557658     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-04-01335.1999     Document Type: Article

References (58)

1. Agrawal S, Sarin PS, Zamecnik M, Zamecnik PC (1992) Cellular uptake and anti-HIV activity of oligonucleotides and their analogs. In: Gene regulation: biology of antisense RNA and DNA (Erickson RP, des Izant JG, eds), pp 273-228. New York: Raven.
2. Akins PT, Liu PK, Hsu CY (1996) Immediate early gene expression in response to cerebral ischemia: friend or foe? Stroke 27:1682-1687.
3. An G, Lin T-N, Liu J-S, Xue J-J, He Y-Y, Hsu CY (1993) Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann Neurol 33:457-464.
4. Chiasson BJ, Hooper ML, Murphy PR, Robertson HA (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur J Pharmacol 227:451-453.
5. Chiasson BJ, Armstrong JN, Hooper ML, Murphy PR, Robertson HA (1994) The application of antisense oligonucleotide technology to the brain: some pitfalls. Cell Mol Neurobiol 14:507-521.
6. Cirelli C, Pompeiano M, Tononi G (1995a) Sleep-waking changes after c-fos antisense injections in the medial preoptic area. NeuroReport 6:801-805.
7. Cirelli C, Pompeiano M, Tononi G (1995b) In vivo antisense approaches to the role of immediate early gene expression in the brain. Regul Pept 59:1551-1621.
8. Colotta F, Polentarutti N, Sironi M, Mantovani A (1992) Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267:18278-18283.
9. Curran T, Miller AD, Zokas L, Verma IM (1984) Spiral and cellular Fos protein: a comparative analysis. Cell 36:259-268.
10. D'Mello SR, Jiang C, Lamberti C, Martin SC, Heinrich G (1992) Differential regulation of the nerve growth factor and brain-derived neurotrophic factor genes in L929 mouse fibroblasts. J Neurosci Res 33:519-526.
11. Dragunow M, Tse C, Glass M, Lawlor P (1994) c-fos antisense reduces expression of Krox 24 in rat caudate and neocortex. Cell Mol Neurobiol 14:395-405.
12. Edwards SA, Rundell YK, Adamson ED (1988) Expression of c-fos antisense RNA inhibits the differentiation of F9 cells to parietal endoderm. Dev Biol 129:91-102.
13. Field SJ, Johnson RS, Mortensen RM, Papaioannou VE, Spiegelman BM, Greenberg ME (1992) Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc Natl Acad Sci USA 89:9306-9310.
14. Funato T, Yoshida E, Jiao L, Tone T, Kashani-Sabet M, Scanlon KJ (1992) The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas. Adv Enzyme Regul 32:195-209.
15. Ghosh A, Carnahan J, Greenberg ME, (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618-1623.
16. Gillardon F, Shutella T, Uhlmann E, Holshoer F, Zimmerman M, Behl C (1996) Activation of c-Fos contributes to amyloid b-peptide-induccd neurotoxicity. Brain Res 706:169-172.
17. Gu ZZ, Pan C, Cui JK, Klebec M, Shenaq S, Liu PK (1997) Gene expression and apoptosis in the spinal cord neurons after peripheral nerve damage. Neurochem Int 30:417-426.
18. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P (1988) c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55:917-924.
19. Hefti F, Hartikka J, Knusel B (1989) Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 10:515-533.
20. Heilig M, Engel JA, Soderpalm B (1993) c-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur J Pharmacol 236:339-340.
21. Hengerer B, Lindholm D, Heumann R, Ruther U, Wagner EF, Thoenen H (1990) Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci USA 87:3899-3903.
22. Holt JT, Gopal TV, Moulton AD, Nienhuis AW (1986) Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci USA 83:4794-4798.
23. Hooper ML, Chiasson BJ, Robertson HA (1994) Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of fos and produces a behavioral effect. Neuroscience 63:917-924.
24. Kerr LD, Holt JT, Matrisian LM (1988) Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242:1424-1427.
25. Kornberg A (1980) Terminal deoxynucleotidyl transferase. In: DNA replication, pp 225-229. San Francisco: Freeman.
26. Kruijer W, Schubert D, Verma IM (1985) Induction of the protooncogene fos by nerve growth factor. Proc Natl Acad Sci USA 82:7330-7334.
27. Levi BZ, Ozato K (1988) Constitutive expression of c-fos antisense RNA blocks c-fos gene induction by interferon and by phorbol ester and reduces c-myc expression in F9 embryonal carcinoma cells. Genes Dev 2:554-566.
28. Levi BZ, Kasik JW, Ozato K (1988) c-fos antisense RNA blocks expression of c-fos gene in F9 embryonal carcinoma cells. Cell Differ Dev 258:95-101.
29. Lindvall O, Ernfors P, Bengzon J, Kokaia Z, Smith ML, Siesjo BK, Persson H (1992) Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 89:648-652.
30. Liu PK (1993) Enhanced expression in the α-type DNA polymerase genes reduces AZT-cytotoxicity in hamster tr5 cells. Somatic Cell Mol Genet 19:211-220.
31. Liu PK, Salminen A, He YY, Jiang MH, Xue JJ, Liu JS, Hsu CY (1994) Suppression of ischemia-induced Fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA. Ann Neurol 36:566-576.
32. Macgregor PF, Abate C, Curran T (1990) Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1. Oncogene 5:451-458.
33. Maisonpierre PC, Le Beau MM, Espinosa III R, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME, Yancopoulos GD (1991) Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10:558-568.
34. Mercola D, Rundell A, Westwick J, Edwards SA (1987) Antisense RNA to the c-fos gene: restoration of density-dependent growth arrest in a transformed cell line. Biochem Biophys Res Commun 147:288-294.
35. Mirabelli CK, Crooke ST (1993) Antisense oligonucleotides in the context of modern molecular drug discovery and development. In: Antisense research and applications (Crooke ET, Lebleu B, eds), pp 7-35. Boca Raton, FL: CRC.
36. Nishikura K, Murray HM (1987) Antisense RNA of protooncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol Cell Biol 7:637-649.
37. Phillips HS, Hains JM, Laramee GR, Rosenthal A, Winslow JW (1990) Wide spread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science 250:290-294.
38. Phillips HS, Haines JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7:695-702.
39. Quercia S, Chang SL (1996) Antisense oligodeoxynucleotide attenuates in vivo expression of c-fos in the paraventricular hypothalamic nucleus of the rat brain. Neurosci Lett 209:89-92.
40. Rosario CM, Yandava BD, Kosaras B, Zurakowski D, Sidman RL, Snyder EY (1997) Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. Development 124:4213-4224.
41. Roulston A, Reinhard C, Amiri P, Williams LT (1998) Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 273:10232-10239.
42. Sagar SM (1993) Expression of c-fos protein in brain: metabolic mapping at the cellular level. Ann Neurol 33:437-438.
43. Sagar SM, Sharp FR, Curran T (1988) Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240:1328-1331.
44. Salminen A, Liu PK, Hsu CY (1995) Alteration of transcription factor binding activities in the ischemic rat brain. Biochem Biophys Res Commun 212:939-944.
45. Scanlon KJ, Jiao L, Funato T, Wang W, Tine T, Rossi JJ, Kashani-Sabet M (1991) Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc Natl Acad Sci USA 88:10591-10595.
46. Schlingensiepen KH, Wollnik F, Kunst M, Schlingensiepen R, Herdegen T, Brysch W (1994) The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo. Cell Mol Neurobiol 14:487-505.
47. Schönthal A, Herrlic P, Rahmsdorf HJ, Ponta H (1988) Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogene and phorbol esters. Cell 54: 325-334.
48. Sharp FR (1994) The sense of antisense fos oligonucleotides. Ann Neurol 36:566-576.
49. Sharp JW, Sagar SM, Hisanaga K, Jasper P, Sharp FR (1991) The NMDA receptor mediates cortical induction of fos and fos-related antigens following cortical injury. Exp Neurol 109:323-332.
50. Sheng M, McFadden G, Greenberg ME (1990) Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 4:571-582.
51. Simonson MS (1994) Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells. Am J Physiol 267:F805-815.
52. Snider WD (1994) Functions of the neurotrophins during nervous system development: what the knockdowns are teaching us. Cell 77:627-638.
53. Snyder EY, Park KI, Flax JD, Liu S, Rosario CM, Yandava BD, Aurora S (1997) Potential of neural "stem-like" cells for gene therapy and repair of the degenerating central nervous system. Adv Neurol 72:121-132.
54. Wetmore C, Ernfors P, Persson H, Olson L (1990) Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol 109:141-152.
55. Whitesell L, Geselowitz D, Chavany C, Fahmy B, Walbridge S, Alger JR, Neckers LM (1993) Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc Natl Acad Sci USA 90:4665-4669.
56. Yakubov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte AS, Yurchenko LV, Vlassovm VV (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 86:6454-6458.
57. Yu K, Lu D, Rowland NE, Raizada MK (1996) Angitensin II regulation of tyrosine hydroxylase gene expression in the neuronal cultures of normotensive and spontaneously hypertensive rats. Endocrinology 137:3566-3576.
58. Zheng M, Heinrich G (1988) Structural and functional analysis of the promoter region of the nerve growth factor gene. Brain Res 427: 133-140.